Vendor Neutral Archive (VNA) and PACS Market Size
Vendor Neutral Archive (VNA) and PACS Market reached US$ 4.62 billion in 2024 and is expected to reach US$ 9.72 billion by 2032, growing with a CAGR of 9.75% during the forecast period 2025-2032.
The increasing requirement for universal medical image archiving, cheaper data storage costs and high-level interfacing with the Electronic Health Records (EHR) market are anticipated to be key drivers of the market in question. Additionally, the increasing expectation for digitalization of healthcare systems has driven the demand for medical archiving.
The July 2021 Diagnostics Journal study article identified the persistent generation of enormous amounts of imaging data in routine clinical practice. Consequently, archives are being built on a regular basis and new ambitious efforts to build gigantic medical imaging libraries have appeared across the globe. Consequently, studies and surveys identify an enormous need for medical imaging archives, which would likely drive the growth of the holistic market even faster.
Vendor Neutral Archive (VNA) and PACS Market Trend
The participation of leading global companies in increasing enterprise imaging is a key industry trend of the global vendor neutral archive and PACS market. For instance, in November 2021, GE Healthcare introduced a next-generation, cloud-based picture archiving and communication system (PACS) to help healthcare companies keep pace with rapidly growing technologies.
The given reasons are accountable for market growth, which is estimated to pick up pace during the forecast period. The availability of long-term data that drives service providers' decisions and the long product life cycle are some factors that are likely to hinder market growth.
Vendor Neutral Archive (VNA) and PACS Market Dynamics
Growing Adoption in Patient Care and Production Launches
The explosive growth of medical imaging data, driven by the enhancement of imaging technology and the digitization of healthcare records, requires the sophistication of data handling systems. Healthcare professionals manage extensive amounts of imaging data, including X-rays, MRIs and CT scans, requiring speedy systems for storing, retrieving and disseminating this data. VNA and PACS play a key role in enabling healthcare providers to utilize medical imaging data for accurate diagnosis, treatment planning and ongoing monitoring of patient progress.
Innovation, product launches and continued activity by top players in the industry are driving the segment ahead. To illustrate, ScImage, Inc., a top cloud-based enterprise imaging and reporting solutions provider, launched its PICOM365 enterprise imaging process in February of 2022. This PICOM365 offers the full functionality of on-premises PACS software systems and is driven by Microsoft Azure Cloud. Due to the above factors, the category is forecast to grow over the forecast period.
Lack of Standardization and High Costs
The lack of standard processes and interoperability frameworks makes data sharing and collaboration between healthcare firms difficult, hindering easy exchange of medical images and patient data. Healthcare professionals therefore encounter interoperability challenges in gathering patient information from heterogeneous systems or moving images across institutions, leading to delays in clinical workflows and potentially compromising patient care.
Also, the enormous installation and maintenance expenses related to VNA and PACS system deployment, such as the investment in infrastructure, software and training, restrict adoption, especially among resource-constrained healthcare institutions. Therefore, the continuous expenses related to system maintenance, system upgrades and cybersecurity updates aggravate the financial burden on healthcare institutions.
Vendor Neutral Archive (VNA) and PACS Market Segment Analysis
The global vendor neutral archive (VNA) and PACS market is segmented based on imaging modality, type, mode of delivery, usage model and region.
Vendor Neutral Archive (VNA) and PACS Market, By Mode of Delivery
Conventional Approach And Ease Of Operation In The On-premise (Premise) Drives Growth
The on-premise delivery option allows for tailored integration with other existing corporate systems and this adds security since servers and information are located physically at service providers' offices. Customers opt for on-premise delivery when they require an upgrade to newer technology or modification of existing legacy systems. End users and service providers opt for on-premise delivery because VNA and PACS technologies are new to them.
Based on an article published by Cleo Integration, a cloud integration platform, in May 2022, on-premises software was delivered and hosted in-house within a physical office instead of being hosted on a vendor-provided cloud. These are operated under company control, whereas systems and data remain under business control. Security for mode of delivery is therefore expected to drive growth.
Vendor Neutral Archive (VNA) and PACS Market Geographical Share
Rising Demand for Standardization of Medical Picture Archiving in North America
The North America vendor-neutral archive (VNA) and PACS market is expected to grow strongly because of increased demand for universal medical picture archiving, declining cost of data storage and VNA compatibility with legacy data archival systems. Besides these reasons, the advanced infrastructure of healthcare IT, presence of large companies and efforts undertaken by market participants in nations like the United States are all contributing factors to the industry's growth.
For instance, in April 2022, Sectra signed an agreement with North York General Hospital (NYGH) in Canada. For storage and reviewing images, NYGH will implement Sectra's enterprise imaging solution's radiology and breast imaging modules and the vendor-neutral archive (VNA). It will enable NYGH to streamline radiological reading productivity and maximize existing workflows, leading to improved patient care without adding to staff workload. Therefore, developments in North American nations are expected to propel the market-researched growth in the region.
Sustainability Analysis
The VNA and PACS market is central to sustainability in the healthcare imaging environment by digitizing, consolidating and centralizing data storage and access substantially lowering the environmental burden historically linked with physical film processing, printing and duplicate data centers. By doing away with the requirement for physical storage, transportation of film and paper diagnostics, healthcare institutions minimize waste, pollution and energy consumption.
In addition, VNAs facilitate long-term archiving by bringing together imaging information from various modalities and vendors into one platform, minimizing infrastructure redundancy and decreasing data center energy usage. Current cloud-based VNA and PACS solutions are also becoming greener with their alignment with green IT practices. The platforms are being implemented in energy-efficient carbon-neutral cloud infrastructures, allowing diagnostic centers and hospitals to decrease their IT carbon footprint.
Vendor Neutral Archive (VNA) and PACS Market Major Players
The major global players in the market include Agfa-Gevaert Group, Dell Technologies Inc., FUJIFILM Holdings Corporation, GE Healthcare, IBM Corporation, Koninklijke Philips NV, Lexmark International Inc., McKesson Corporation, Novarad Corporation and Siemens Healthineers AG.
Vendor Neutral Archive (VNA) and PACS Market Company Share Analysis
Key Developments
In January 2024, RAMSoft (Canada) launched OmegaAI, an EMR imaging system. The product is a cloud-native, serverless imaging EMR software platform that integrates VNA, Enterprise Imaging, PACS, RIS, streamlined image exchange/sharing, routing and storage, a zero-footprint (ZFP) viewer, unified worklist, radiology reporting, document management, peer, patient portal and a real-time business intelligence and analytics solution.
Why Choose DataM?
Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Imaging Modality
- 3.2. Snippet by Type
- 3.3. Snippet by Mode of Delivery
- 3.4. Snippet by Usage Model
- 3.5. Snippet by Region
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Growing Adoption in Patient Care and Production Launches
- 4.1.2. Restraints
- 4.1.2.1. Lack of Standardization and High Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory and Compliance Analysis
- 5.5. Sustainability Analysis
- 5.6. DMI Opinion
- 6. By Imaging Modality
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
- 6.1.2. Market Attractiveness Index, By Imaging Modality
- 6.2. Angiography*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.3. Mammography
- 6.4. Computed Tomography
- 6.5. Magnetic Resonance Imaging
- 6.6. Ultrasound
- 6.7. Other Imaging Modalities
- 7. By Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
- 7.2. PACS*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. VNA Software
- 8. By Mode of Delivery
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 8.1.2. Market Attractiveness Index, By Mode of Delivery
- 8.2. On-premise (Premise)*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Hybrid
- 8.4. Cloud-hosted
- 9. By Usage Model
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
- 9.1.2. Market Attractiveness Index, By Usage Model
- 9.2. Single Department*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Multiple Departments
- 9.4. Multiple Sites
- 10. By Region
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
- 10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
- 11. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
- 11.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.1.2.1. US
- 11.1.2.2. Canada
- 11.1.2.3. Mexico
- 11.2. Europe
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. Germany
- 11.2.7.2. UK
- 11.2.7.3. France
- 11.2.7.4. Italy
- 11.2.7.5. Spain
- 11.2.7.6. Rest of Europe
- 11.3. South America
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Brazil
- 11.3.7.2. Argentina
- 11.3.7.3. Rest of South America
- 11.4. Asia-Pacific
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. China
- 11.4.7.2. India
- 11.4.7.3. Japan
- 11.4.7.4. Australia
- 11.4.7.5. Rest of Asia-Pacific
- 11.5. Middle East and Africa
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage Model
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Positioning/Share Analysis
- 12.3. Mergers and Acquisitions Analysis
- 13. Company Profiles
- 13.1. Agfa-Gevaert Group*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
- 13.2. Dell Technologies Inc.
- 13.3. FUJIFILM Holdings Corporation
- 13.4. GE Healthcare
- 13.5. IBM Corporation
- 13.6. Koninklijke Philips NV
- 13.7. Lexmark International Inc.
- 13.8. McKesson Corporation
- 13.9. Novarad Corporation
- 13.10. Siemens Healthineers AG (*LIST NOT EXHAUSTIVE)
- 14. Appendix
- 14.1. About Us and Services
- 14.2. Contact Us
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook